Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population
暂无分享,去创建一个
[1] V. Mohan,et al. Association of lipoprotein lipase Hind III and Ser 447 Ter polymorphisms with dyslipidemia in Asian Indians. , 2006, The American journal of cardiology.
[2] D. Ge,et al. Linkage and linkage disequilibrium analysis of the lipoprotein lipase gene with lipid profiles in Chinese hypertensive families. , 2005, Clinical science.
[3] A. Barnett,et al. Association of simple anthropometric measures of obesity with visceral fat and the metabolic syndrome in male Caucasian and Indo‐Asian subjects , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[4] P. Majumder,et al. Ethnic India: a genomic view, with special reference to peopling and structure. , 2003, Genome research.
[5] V. Mohan,et al. The Chennai Urban Rural Epidemiology Study (CURES)--study design and methodology (urban component) (CURES-I). , 2003, The Journal of the Association of Physicians of India.
[6] S. Joshi. Metabolic syndrome--emerging clusters of the Indian phenotype. , 2003, The Journal of the Association of Physicians of India.
[7] V. Mohan,et al. The changing scenario of the diabetes epidemic: implications for India. , 2002, The Indian journal of medical research.
[8] D. Simonson,et al. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. , 2001, The Journal of clinical endocrinology and metabolism.
[9] L. Wasserman,et al. Genomic control, a new approach to genetic-based association studies. , 2001, Theoretical population biology.
[10] G. Renier,et al. Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs. , 2001, Diabetes.
[11] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[12] S. Grundy,et al. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. , 1999, The Journal of clinical endocrinology and metabolism.
[13] E. Boerwinkle,et al. The Asn9 variant of lipoprotein lipase is associated with the — 93G promoter mutation and an increased risk of coronary artery disease , 1998, Clinical genetics.
[14] M. Hayden,et al. Ethnic variation and in vivo effects of the -93t-->g promoter variant in the lipoprotein lipase gene. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[15] P. Talmud,et al. A common mutation in the lipoprotein lipase gene promoter, -93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[16] S. Haffner,et al. Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites. , 1997, Diabetes research and clinical practice.
[17] S. Deeb,et al. Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease. , 1996, Journal of lipid research.
[18] J Auwerx,et al. PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene. , 1996, The EMBO journal.
[19] J. Auwerx,et al. Expression and Regulation of the Lipoprotein Lipase Gene in Human Adrenal Cortex* , 1996, The Journal of Biological Chemistry.
[20] J. Auwerx,et al. Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. , 1996, Atherosclerosis.
[21] H. Endo,et al. A silencer element for the lipoprotein lipase gene promoter and cognate double- and single-stranded DNA-binding proteins , 1995, Molecular and cellular biology.
[22] R. Eckel,et al. Characterization of a high affinity octamer transcription factor binding site in the human lipoprotein lipase promoter. , 1992, Archives of biochemistry and biophysics.
[23] S. Enerbäck,et al. Characterization of the human lipoprotein lipase (LPL) promoter: evidence of two cis-regulatory regions, LP-alpha and LP-beta, of importance for the differentiation-linked induction of the LPL gene during adipogenesis , 1992, Molecular and cellular biology.
[24] M. Marmot,et al. Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in South Asians and Europeans , 1992, Diabetologia.
[25] M. Sheng,et al. Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences , 1988, Molecular and cellular biology.
[26] J. Levy,et al. Insulin Resistance in Patients of Asian Indian and European Origin with Non-Insulin Dependent Diabetes , 1987, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[27] V. Mohan,et al. Serum immunoreactive insulin responses to a glucose load in Asian Indian and European Type 2 (non-insulin-dependent) diabetic patients and control subjects , 1986, Diabetologia.
[28] Anoop Misra,et al. Insulin resistance syndrome (metabolic syndrome) and Asian Indians , 2002 .
[29] G. Renier,et al. Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose : role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[30] E. Boerwinkle,et al. The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group. , 1998 .